PDCD1 and hepatocellular carcinoma: Continuous and effective antiviral treatment was shown to improve the prognosis of HCC patients receiving anti-PD-1 blockade with high viral loads in our previous study (recently accepted article, https://doi.org/10.21037/atm-21-3020).